CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2

被引：24
|
作者：
Chen, Xiong [1 ]
Zheng, Peichan [2 ]
Xue, Zengfu [3 ]
Li, Jie [1 ]
Wang, Wenwu [1 ]
Chen, Xi [1 ]
Xie, Fangwei [1 ]
Yu, Zongyang [1 ]
Ouyang, Xuenong [1 ]
机构：
[1] Nanjing Mil Command, Dept Med Oncol, Fuzhou Gen Hosp, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Sch Basic Med Sci, Dept Anat, Fuzhou, Fujian, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Dept Digest Dis, Xiamen, Fujian, Peoples R China
来源：
APOPTOSIS | 2013年 / 18卷 / 07期
基金：
中国国家自然科学基金;
关键词：
CacyBP/SIP; Multidrug resistance; Apoptosis; Pancreatic cancer; BINDING-PROTEIN; EXPRESSION; TUMORIGENICITY; TARGET;
D O I：
10.1007/s10495-013-0831-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Our former report indicates that calcyclin-binding protein or Siah-1-interacting protein (CacyBP/SIP) is over-expressed in the SGC7901/ADR cell line. However, the potential role of CacyBP/SIP in the development of multidrug resistance (MDR) of pancreatic cancer is still uncertain. In this paper, we investigated the role of CacyBP/SIP in MDR of pancreatic cancer cells and its possible underlying mechanisms, and found that CacyBP/SIP was over-expressed in the Gemcitabine induced MDR pancreatic cancer cell PC-3/Gem compared with its parental cell PC-3. Up-regulation of CacyBP/SIP expression could enhance resistance of chemotherapy drugs on PC-3 cells and inhibit Adriamycin-induced apoptosis accompanied by decreased accumulation of intracellular Adriamycin. Furthermore, CacyBP/SIP could significantly up-regulate the expression of P-gp, Bcl-2, and the transcription of the MDR1 gene. In addition, the decrease of CacyBP/SIP expression using RNA interference or P-gp inhibitor could partially reverse CacyBP/SIP-mediated MDR. In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.
引用
收藏
页码：861 / 869
页数：9
相关论文
共 50 条
  • [1] CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2
    Xiong Chen
    Peichan Zheng
    Zengfu Xue
    Jie Li
    Wenwu Wang
    Xi Chen
    Fangwei Xie
    Zongyang Yu
    Xuenong Ouyang
    Apoptosis, 2013, 18 : 861 - 869
  • [2] Phospho akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax
    Han, Z.
    Hong, L.
    Han, Y.
    Wu, K.
    Han, S.
    Shen, H.
    Li, C.
    Yao, L.
    Qiao, T.
    Fan, D.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (02) : 261 - 268
  • [3] Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp
    Liu, Xinyue
    Li, Linjing
    Li, Jing
    Cheng, Yan
    Chen, Jing
    Shen, Minghui
    Zhang, Shangdi
    Wei, Hulai
    ONCOLOGY REPORTS, 2016, 35 (05) : 3018 - 3024
  • [4] DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2
    Liu, Hao-Yue
    Duan, Guang-Ling
    Xu, Rui-Yuan
    Li, Xiao-Ran
    Xiao, Lin
    Zhao, Le
    Ma, Zhao-Xia
    Xu, Xing-Wang
    Qiu, Le-Jia
    Zhu, Zheng-Ming
    Chen, He-Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 519 (01) : 73 - 80
  • [5] Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp
    He, Qingchun
    Zhang, Guiying
    Hou, Defu
    Leng, Aiming
    Xu, Meihua
    Peng, Jie
    Liu, Ting
    ONCOLOGY REPORTS, 2011, 25 (01) : 237 - 243
  • [6] Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells
    Chen, Xuan-Yu
    Wu, Zhuo-Xun
    Wang, Jing-Quan
    Teng, Qiu-Xu
    Tang, Hailin
    Liu, Qianwen
    Chen, Zhe-Sheng
    Chen, Wenkuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] ERK/BCL-2 Pathway in the Resistance of Pancreatic Cancer to Anoikis
    Galante, Joseph M.
    Mortenson, Melinda M.
    Bowles, Tawnya L.
    Virudachalam, Subbulakshmi
    Bold, Richard J.
    JOURNAL OF SURGICAL RESEARCH, 2009, 152 (01) : 18 - 25
  • [8] Sunitinib Reverse Multidrug Resistance in Gastric Cancer Cells by Modulating Stat3 and Inhibiting P-gp Function
    Zhang, Ye
    Wang, Qiong
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (02) : 575 - 581
  • [9] Pien Tze Huang induces apoptosis in multidrug-resistant U2OS/ADM cells via downregulation of Bcl-2, survivin and P-gp and upregulation of Bax
    Zhang, Yan
    Wang, Qihong
    Niu, Susheng
    Liu, Junning
    Zhang, Li
    ONCOLOGY REPORTS, 2014, 31 (02) : 763 - 770
  • [10] Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation
    Petropoulos, Sophie
    Gibb, William
    Matthews, Stephen G.
    BRAIN RESEARCH, 2010, 1357 : 9 - 18
12345